Leaflet STRIVERDI RESPIMAT 2.5mcg inhalation solution
Product code: W60771005 Quantity: 3
Indicated for: chronic obstructive pulmonary disease
Route of administration: inhalation
Substance: olodaterol (beta-2 adrenergic agonist)
ATC: R03AC19 (Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists)
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
Olodaterol is a long-acting beta-2 adrenergic agonist used for the treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the smooth muscles of the airways, making breathing easier.
The medication is administered via an inhaler, usually once daily, as directed by a doctor. It is important for patients to use the medication regularly to achieve maximum benefits.
Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include tremors, palpitations, headaches, and dry mouth. In rare cases, severe reactions such as paradoxical bronchospasm or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about STRIVERDI RESPIMAT 2.5mcg
- Substance: olodaterol
- Date of latest medicines list: 01-07-2021
- Product code: W60771005
- Concentration: 2.5mcg
- Pharmaceutical form: inhalation solution
- Quantity: 3
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.